Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

Trial ID or NCT#

NCT02424955

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to prospectively analyze the value of 3D ultrasound perfusion imaging for treatment planning, the prediction of therapy success, and to monitor the treatment response in patients with a primary or metastatic liver tumor undergoing radiation treatment.

Official Title

Feasibility of 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Contact us to find out if this trial is right for you.

Contact

Jen-Yeu Wang
650-723-3110

View on ClinicalTrials.gov